Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Phrenic Nerve Stimulation for Central Sleep Apnoea
Author(s): Jonathan Na , Miguel Valderrábano , Paul Schurmann Added: 1 month ago

Electrophysiology & Arrhythmia

Heart Failure
Home Sleep Apnoea Testing in Heart Failure
Author(s): Rebecca Steinberg , Andrew R Spector , Todd McVeigh , et al Added: 2 months ago

Heart Failure
Transvenous Phrenic Nerve Stimulation in Central Sleep Apnoea/Heart Failure
Author(s): Tarek Bekfani , Joseph D Abraham , William T Abraham Added: 5 months ago

Heart Failure
Diagnostic Testing for Sleep Apnea in Heart Failure
Author(s): Marat Fudim Added: 7 months ago
In this short interview, Dr Marat Fudim offers a preview of his upcoming manuscript, set to appear in the Sleep Disordered Breathing in Heart Failure special focus collection in Cardiac Failure Review. He discusses the evolving role of home sleep testing in diagnosing sleep apnea in patients with heart failure, addressing key considerations in clinical workflows and patient selection.Watch now to… View more

Heart Failure
Impact of Hypopnoea Classifications in Heart Failure
Author(s): Sébastien Baillieul , Renaud Tamisier , Jean-Louis Pépin Added: 1 month ago

Guidelines & Statements

Heart Failure
Undiagnosed Sleep Apnoea Linked to Adverse Myocardial Remodelling in Hypertrophic Cardiomyopathy
Added: 4 months ago Source:  Radcliffe Cardiology
Sleep-disordered breathing (SDB), a condition mediated by intermittent hypoxaemia and autonomic dysregulation, is a well-established contributor to cardiovascular morbidity. A new prospective cohort study suggests that patients with hypertrophic cardiomyopathy (HCM) are particularly at risk, revealing a high prevalence of previously undiagnosed SDB in this population. The research links the… View more

Heart Failure

Imaging & Diagnostics
Emerging Therapies for Obstructive Hypertrophic Cardiomyopathy
Author(s): Emily Li-Wen Chu , Daniel Seung Kim , Ahmad Masri Added: 2 months ago

Heart Failure

Intervention
PAP Therapies for HF: What Do the Trials Tell Us?
Author(s): Jan Pec , Michael Arzt Added: 1 month ago

Guidelines & Statements

Heart Failure
AHA 25: MAPLE-HCM Responder Analysis
Author(s): Andrew Wang Added: 2 months ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive… View more

Heart Failure
ESC 25: The ODYSSEY-HCM Study
Author(s): Milind Y Desai Added: 4 months ago
ESC Congress 2025 - ODYSSEY-HCM finds no improvements in patients with non-obstructive cardiomyopathy when treated with mavacamten.Dr Milind Desai (Cleveland Clinic, US) joins us to discuss findings from the ODYSSEY-HCM trial, evaluating the safety, tolerability, and efficacy of mavacamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy.The ODYSSEY-HCM study was a… View more

Heart Failure